iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax

/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that it has completed the efficacy evaluation study of BAL200, a novel...

Related Keywords

Boston ,Massachusetts ,United States ,Seoul ,Soult Ukpyolsi ,South Korea ,Sang Hyeon ,Kyonggi Do , ,Ntron Biotechnology Inc ,Bd Team ,Tae Kyu Tk Bd Team Leader ,Inhalational Anthrax ,Orphan Drug Designation ,Post Exposure Prophylaxis ,Animal Efficacy Rule ,Animal Rule ,Kyung Won ,Vice President ,Tae Kyu ,Intron Biotechnology ,Nc ,